UGA Researchers Break Ground on Flu Vaccine

Researchers at the University of Georgia and Sanofi Pasteur, a multinational pharmaceutical company announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Using a technique called Computationally Optimized Broadly Reactive Antigen, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.

Sanofi Pasteur and UGA researchers are set to present their data tomorrow, March 30, at the World Vaccine Congress located in Washington, D.C.

Tags:


Notice: Undefined offset: 0 in /var/www/html/gradynewsource/public_html/wordpress/wp-content/themes/onfleek/inc/df-core/views/df-content/df-post-layout-5.php on line 201

You May Also Like

Dawgtoberfest Informs UGA Students About Health

When you hear Dawgtoberfest, what do you think of? If you thought about beer, ...

Burglary At Busbee Hall

Athens, GA- The dorms at East Campus Village aren't as safe as you think. ...

New Group Study Rooms Coming to Main Library in Fall 2019

Among those quietly studying, sighs of frustration can be heard as students search for ...

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close